DE60018186D1 - Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie - Google Patents

Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie

Info

Publication number
DE60018186D1
DE60018186D1 DE60018186T DE60018186T DE60018186D1 DE 60018186 D1 DE60018186 D1 DE 60018186D1 DE 60018186 T DE60018186 T DE 60018186T DE 60018186 T DE60018186 T DE 60018186T DE 60018186 D1 DE60018186 D1 DE 60018186D1
Authority
DE
Germany
Prior art keywords
retinopathy
treating
preventing
liferative
prepro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60018186T
Other languages
English (en)
Other versions
DE60018186T2 (de
Inventor
Shizue Nakagawa
Yasutaka Nagisa
Hitoshi Ikeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60018186D1 publication Critical patent/DE60018186D1/de
Publication of DE60018186T2 publication Critical patent/DE60018186T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE60018186T 1999-04-28 2000-04-27 Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie Expired - Lifetime DE60018186T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12149899 1999-04-28
JP12149899 1999-04-28
PCT/JP2000/002766 WO2000066161A1 (fr) 1999-04-28 2000-04-27 Preventifs / remedes / inhibiteurs de progression pour retinopathie simplex ou retinopathie preproliferante

Publications (2)

Publication Number Publication Date
DE60018186D1 true DE60018186D1 (de) 2005-03-24
DE60018186T2 DE60018186T2 (de) 2005-12-29

Family

ID=14812676

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60018186T Expired - Lifetime DE60018186T2 (de) 1999-04-28 2000-04-27 Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie

Country Status (23)

Country Link
US (2) US7064141B1 (de)
EP (1) EP1197223B1 (de)
KR (1) KR100865059B1 (de)
CN (1) CN1172719C (de)
AT (1) ATE289204T1 (de)
AU (1) AU774799B2 (de)
BR (1) BR0010084A (de)
CA (1) CA2371554C (de)
CZ (1) CZ301913B6 (de)
DE (1) DE60018186T2 (de)
DK (1) DK1197223T3 (de)
ES (1) ES2233362T3 (de)
HU (1) HU226948B1 (de)
MX (1) MXPA01010923A (de)
NO (1) NO327446B1 (de)
NZ (1) NZ514855A (de)
PL (1) PL196895B1 (de)
PT (1) PT1197223E (de)
RU (1) RU2239454C2 (de)
SI (1) SI1197223T1 (de)
SK (1) SK286859B6 (de)
WO (1) WO2000066161A1 (de)
ZA (1) ZA200108527B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
US20050032854A1 (en) * 2001-12-03 2005-02-10 Kiminori Kawahara Insulin resistance improving agents
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US8980870B2 (en) 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
EP1614428A4 (de) * 2003-04-15 2010-01-06 Sankyo Co Arzneimittel zur vorbeugung oder behandlung angiogener augenerkrankungen
US20050038093A1 (en) * 2003-05-02 2005-02-17 Boehringer Ingelheim International Gmbh Treating diabetic retinopathy with angiotensin II receptor blockers
WO2006024092A1 (en) * 2004-08-31 2006-03-09 Newsouth Innovations Pty Limited Vegf inhibition
MX366895B (es) * 2004-11-05 2019-07-30 Boehringer Ingelheim Int Gmbh Star Comprimido bicapa que comprende telmisartán y amlodipina.
PL1872783T3 (pl) * 2005-04-21 2012-05-31 Santen Pharmaceutical Co Ltd Środek leczniczy w schorzeniach rogówkowo-spojówkowych
US20090270474A1 (en) * 2005-12-06 2009-10-29 Keiichi Shibagaki Therapeutic Agent for Keratoconjunctival Disorder
TWI415634B (zh) * 2007-03-28 2013-11-21 Takeda Pharmaceutical 固態醫藥組成物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027211D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
US5591762A (en) 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
DE4201554A1 (de) 1992-01-22 1993-07-29 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9110635D0 (en) 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
ZA931063B (en) 1992-02-17 1993-09-23 Ciba Geigy Treatment of glaucoma.
GB9223860D0 (en) * 1992-11-13 1993-01-06 Glaxo Group Ltd Chemical compounds
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
JPH0789957A (ja) 1993-09-22 1995-04-04 Nissan Chem Ind Ltd ビフェニルメチルアミン誘導体
CA2181461A1 (en) * 1994-02-08 1995-08-17 Alica Huxley Treatment of normotensive glaucoma with angiotensin ii antagonists
JPH09210183A (ja) * 1996-01-31 1997-08-12 Suzuki Motor Corp 動力伝達装置
CZ293345B6 (cs) * 1996-03-29 2004-04-14 Smithkline Beecham Corporation Dihydrát monomethansulfonatu kyseliny (E)-alfa-[2-n-butyl-1-[(4-karboxyfenyl)methyl]-1H-imidazol-5-yl]methylen-2-thiofenpropionové
SI0914158T2 (sl) * 1996-04-05 2006-04-30 Takeda Chemical Industries Ltd Farmacevtska kombinacija, ki vsebuje spojino z angiotenzin II-antagonisticno aktivnostjo in spojino, ki povecuje inzulinsko obcutljivost
TW416953B (en) 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6262102B1 (en) * 1997-06-27 2001-07-17 Smithkline Beecham Corporation Eprosartan monohydrate
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
NZ502644A (en) * 1997-08-06 2002-03-01 Smithkline Beecham Corp Eprosartan arginyl charge-neutralization-complex useful for treating diseases where blockade of the angiotensin II receptor is indicated
ZA991706B (en) 1998-03-04 2000-10-03 Takeda Chemical Industries Ltd Sustained-release preparation for Aii Antagonist, production and use thereof.
CA2336822C (en) 1998-07-10 2009-11-17 Novartis Ag Method of treatment and pharmaceutical composition
FR2783422A1 (fr) 1998-09-21 2000-03-24 Sanofi Sa Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire
JP2000159671A (ja) 1998-12-01 2000-06-13 Takeda Chem Ind Ltd 血管新生阻害剤

Also Published As

Publication number Publication date
BR0010084A (pt) 2002-01-15
AU774799B2 (en) 2004-07-08
WO2000066161A1 (fr) 2000-11-09
ATE289204T1 (de) 2005-03-15
CZ20013804A3 (cs) 2002-04-17
NO327446B1 (no) 2009-06-29
CA2371554A1 (en) 2000-11-09
RU2239454C2 (ru) 2004-11-10
CN1172719C (zh) 2004-10-27
EP1197223A4 (de) 2003-10-29
CA2371554C (en) 2009-06-09
DK1197223T3 (da) 2005-05-30
EP1197223A1 (de) 2002-04-17
ES2233362T3 (es) 2005-06-16
NO20015257D0 (no) 2001-10-26
SK15452001A3 (sk) 2002-04-04
SK286859B6 (sk) 2009-06-05
DE60018186T2 (de) 2005-12-29
CN1348385A (zh) 2002-05-08
HUP0200890A2 (hu) 2002-11-28
KR100865059B1 (ko) 2008-10-23
SI1197223T1 (de) 2005-08-31
PL196895B1 (pl) 2008-02-29
ZA200108527B (en) 2002-10-17
PL350554A1 (en) 2002-12-16
KR20020015315A (ko) 2002-02-27
AU4143400A (en) 2000-11-17
HU226948B1 (en) 2010-03-29
MXPA01010923A (es) 2002-06-21
EP1197223B1 (de) 2005-02-16
PT1197223E (pt) 2005-04-29
US20060189669A1 (en) 2006-08-24
CZ301913B6 (cs) 2010-07-28
US7064141B1 (en) 2006-06-20
NO20015257L (no) 2001-10-26
HUP0200890A3 (en) 2002-12-28
NZ514855A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
BR0109703A (pt) Derivados de piperazina
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
GB0318447D0 (en) Therapeutic agents
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
ECSP055809A (es) Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4
GEP20094638B (en) Benzimidazolone carboxylic acid derivatives
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
SE0104248D0 (sv) Method of treatment
DE60018186D1 (de) Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
LT2004074A (en) Matricines metalproteinazes inhibuojanti kompozicija neoplazinems ligoms gydyti
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
WO2007058639A3 (en) Antibacterial agents
AU2003258176A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
DE60121978D1 (de) 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN
DE60014915D1 (de) Hypoxanthin- und thiohypxanthin-verbindungen
AU2003258177A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
TW200510348A (en) 5-aryltetrazole compounds, compositions thereof, and uses therefor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition